Champions Oncology, Inc. (CSBR) vs Heron Therapeutics, Inc. (HRTX)
A side-by-side comparison of Champions Oncology, Inc. and Heron Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CSBR
Champions Oncology, Inc.
$4.88HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT
HRTX
Heron Therapeutics, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — CSBR vs HRTX
growth of $100 · dividends reinvested · last 10yCSBR +196.0% (+11.5%/yr)HRTX -97.7% (-31.4%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
CSBR HRTX
CSBR vs HRTX: by the numbers
- •CSBR is the larger company ($68M vs $64M market cap).
- •Both run net losses; CSBR's is the smaller (-1.87% vs -22.52% net margin).
- •HRTX grew revenue faster over the past five years (12.73% vs 7.25% CAGR).
Metrics side by side
Valuation
| Metric | CSBR | HRTX |
|---|---|---|
| Forward P/E | 48.80 | N/A |
| P/S ratio | 1.12 | 0.42 |
| P/B ratio | 17.42 | 10.87 |
| EV / EBITDA | 255.71 | N/A |
Profitability
| Metric | CSBR | HRTX |
|---|---|---|
| Gross margin | 49.30% | 70.07% |
| Operating margin | -1.72% | -7.19% |
| Net margin | -1.87% | -22.52% |
| ROE | -29.15% | -492.89% |
| ROIC | -6.75% | -6.79% |
Growth (annualized)
| Metric | CSBR | HRTX |
|---|---|---|
| Revenue CAGR (5Y) | 7.25% | 12.73% |
| Total return CAGR (5Y) | -13.07% | -48.61% |
Frequently asked
- Which has grown faster, CSBR or HRTX?
- Over the past five years, HRTX grew revenue faster — CSBR at a 7.25% CAGR versus HRTX at 12.73%.
- How have CSBR and HRTX total returns compared?
- Over the past 10 years, CSBR delivered 12.07% and HRTX delivered -31.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.